BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang H, Peng W, Shen X, Huang Y, Ouyang X, Dai Y. Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease. Braz J Med Biol Res 2012;45:1308-14. [PMID: 23070235 DOI: 10.1590/s0100-879x2012007500165] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Hu YY, Dong WD, Xu YF, Yao XD, Peng B, Liu M, Zheng JH. Elevated levels of miR-155 in blood and urine from patients with nephrolithiasis. Biomed Res Int 2014;2014:295651. [PMID: 25197634 DOI: 10.1155/2014/295651] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ramezani A, Devaney JM, Cohen S, Wing MR, Scott R, Knoblach S, Singhal R, Howard L, Kopp JB, Raj DS. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study. Eur J Clin Invest 2015;45:394-404. [PMID: 25682967 DOI: 10.1111/eci.12420] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 10.2] [Reference Citation Analysis]
3 Xiong W, Lin Y, Xu L, Tamadon A, Zou S, Tian F, Shao R, Li X, Feng Y. Circulatory microRNA 23a and microRNA 23b and polycystic ovary syndrome (PCOS): the effects of body mass index and sex hormones in an Eastern Han Chinese population. J Ovarian Res 2017;10:10. [PMID: 28193283 DOI: 10.1186/s13048-016-0298-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 3.8] [Reference Citation Analysis]
4 Xiang Y, Guo J, Peng YF, Tan T, Huang HT, Luo HC, Wei YS. Association of miR-21, miR-126 and miR-605 gene polymorphisms with ischemic stroke risk. Oncotarget 2017;8:95755-63. [PMID: 29221163 DOI: 10.18632/oncotarget.21316] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
5 Fourdinier O, Schepers E, Metzinger-Le Meuth V, Glorieux G, Liabeuf S, Verbeke F, Vanholder R, Brigant B, Pletinck A, Diouf M, Burtey S, Choukroun G, Massy ZA, Metzinger L;  European Uremic Toxin Work Group-EUTox. Serum levels of miR-126 and miR-223 and outcomes in chronic kidney disease patients. Sci Rep. 2019;9:4477. [PMID: 30872798 DOI: 10.1038/s41598-019-41101-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
6 Sargazi S, Heidari Nia M, Mirani Sargazi F, Sheervalilou R, Saravani R, Bahrami S, Mirinejad S, Alidadi A. Functional miR143/145 Cluster Variants and Haplotypes Are Associated with Chronic Kidney Disease: a Preliminary Case-Control Study and Computational Analyses. Appl Biochem Biotechnol 2021;193:1532-44. [PMID: 33484447 DOI: 10.1007/s12010-021-03489-w] [Reference Citation Analysis]
7 Zhang W, Li X, Tang Y, Chen C, Jing R, Liu T. miR-155-5p Implicates in the Pathogenesis of Renal Fibrosis via Targeting SOCS1 and SOCS6. Oxid Med Cell Longev 2020;2020:6263921. [PMID: 32587662 DOI: 10.1155/2020/6263921] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
8 Al-Kafaji G, Al-Mahroos G, Al-Muhtaresh HA, Skrypnyk C, Sabry MA, Ramadan AR. Decreased expression of circulating microRNA-126 in patients with type 2 diabetic nephropathy: A potential blood-based biomarker. Exp Ther Med 2016;12:815-22. [PMID: 27446281 DOI: 10.3892/etm.2016.3395] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.8] [Reference Citation Analysis]
9 Dziedzic M, Powrózek T, Orłowska E, Koch W, Kukula-Koch W, Gaweł K, Bednarek-Skublewska A, Małecka-Massalska T, Milanowski J, Petkowicz B, Solski J. Relationship between microRNA-146a expression and plasma renalase levels in hemodialyzed patients. PLoS One 2017;12:e0179218. [PMID: 28614373 DOI: 10.1371/journal.pone.0179218] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
10 Motshwari DD, George C, Matshazi DM, Weale CJ, Davids SFG, Zemlin AE, Erasmus RT, Kengne AP, Matsha TE. Expression of whole blood miR-126-3p, -30a-5p, -1299, -182-5p and -30e-3p in chronic kidney disease in a South African community-based sample. Sci Rep 2022;12:4107. [PMID: 35260775 DOI: 10.1038/s41598-022-08175-3] [Reference Citation Analysis]
11 Buza T, Arick M 2nd, Wang H, Peterson DG. Computational prediction of disease microRNAs in domestic animals. BMC Res Notes 2014;7:403. [PMID: 24970281 DOI: 10.1186/1756-0500-7-403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
12 Zheng C, Zhang J, Chen X, Zhang J, Ding X, You X, Fan L, Chen C, Zhou Y. MicroRNA-155 Mediates Obesity-Induced Renal Inflammation and Dysfunction. Inflammation 2019;42:994-1003. [PMID: 30715692 DOI: 10.1007/s10753-019-00961-y] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yu B, Jiang Y, Wang X, Wang S. An integrated hypothesis for miR-126 in vascular disease. Med Res Arch 2020;8:2133. [PMID: 34222652 DOI: 10.18103/mra.v8i5.2133] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Zhou ZQ, Wang ZK, Zhang L, Ren YQ, Ma ZW, Zhao N, Sun FY. Role of ESAT-6 in renal injury by regulating microRNA-155 expression via TLR4/MyD88 signaling pathway in mice with Mycobacterium tuberculosis infection. Biosci Rep 2017;37:BSR20170021. [PMID: 28655852 DOI: 10.1042/BSR20170021] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]